Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Venuat

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Genetics and Cytogenetics|June 1, 1993
Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66)P Antonini, G Linares, N Gaillard, et al.
Cancer|November 1, 1988
High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type originA M Venuat, C Soria, J Soria, et al.
Biochemical Pharmacology|July 17, 1995
Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoformJ Markovits, S Junqua, F Goldwasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomasD Decaudin, J Bosq, G Tertian, et al.
Leukemia & Lymphoma|August 1, 1997
Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 casesD Decaudin, J Bosq, J N Munck, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Genetics and Cytogenetics|June 1, 1993
Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66)P Antonini, G Linares, N Gaillard, et al.
Cancer|November 1, 1988
High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type originA M Venuat, C Soria, J Soria, et al.
Biochemical Pharmacology|July 17, 1995
Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoformJ Markovits, S Junqua, F Goldwasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomasD Decaudin, J Bosq, G Tertian, et al.
Leukemia & Lymphoma|August 1, 1997
Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 casesD Decaudin, J Bosq, J N Munck, et al.
Pageof 2